Oak Longevity vs CoreAgeRx: pricing, process, and access compared
Oak Longevity vs CoreAgeRx: if you want a fast comparison, Oak emphasizes low flat monthly prices with no subscriptions while CoreAgeRx emphasizes stable flat pricing every month. Early verdict: choose Oak for lowest listed starting pricing and no video visit; choose CoreAgeRx if you prioritize a promise of the same price every month and explicit dose caps.
See Oak Longevity pricing and details
How they differ: five key comparison points
This comparison focuses on the most distinctive supported differences between Oak Longevity and CoreAgeRx: starting price and pricing model, dosing coverage and dose caps, enrollment and clinical review process, membership and billing terms, and regulatory/compounded medication notes. All statements below use only the supplied facts.
1. Starting price and pricing model
Oak Longevity lists semaglutide starting at $133/month and tirzepatide starting at $199/month with a single flat price covering all dosages. CoreAgeRx lists semaglutide at $79/month and tirzepatide at $129/month and emphasizes “Same Price. Every Month.” CoreAgeRx also warns that other programs may raise bills later; CoreAgeRx positions itself as flat monthly pricing with no membership fee.
View CoreAgeRx pricing and flat-rate policy
2. Dosing coverage and limits
Oak advertises “one price covers all dosages” for semaglutide and tirzepatide. CoreAgeRx specifies dose caps in the captured evidence: semaglutide any dose up to 1.0 mg and tirzepatide any dose up to 7.5 mg in the materials reviewed. If dose caps matter, CoreAgeRx documents those upper limits while Oak highlights a one-price-for-all-dosages claim.
3. Enrollment and clinician review
Oak describes an online process with no video call required and asynchronous clinical review by board-certified physicians in your state; it states that treatment is available only when a licensed clinician determines it is medically appropriate. CoreAgeRx notes a 3-minute online visit and also states treatment is available only when a licensed clinician determines it is medically appropriate. Both require clinician review for eligibility.
4. Membership, billing cadence, and shipping
Oak explicitly states no subscriptions, no membership fees, and monthly billing on a non-recurring basis so you choose to renew payment each month; three-month prescriptions are billed upfront and Oak states no refunds are available after physician approval and once medication has shipped. Oak also includes free health coaching and free shipping with tracking in its offering. CoreAgeRx emphasizes no membership fee and a same-price-every-month promise; captured details on shipping timing and refund policy were not published on the landing page evidence provided.
5. Regulatory and product status
Both sources include regulatory notes that compounded medications, when offered, are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Oak explicitly states it offers compounded semaglutide and compounded tirzepatide prepared by licensed compounding pharmacies in the captured materials. CoreAgeRx notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable in the captured evidence.
Side-by-side at a glance
| Criteria | Oak Longevity | CoreAgeRx |
|---|---|---|
| Semaglutide starting price | $133/month | $79/month |
| Tirzepatide starting price | $199/month | $129/month |
| Pricing model | One flat price for all dosages; no subscription | Flat monthly pricing; same price every month; no membership fee |
| Dose coverage | One price covers all dosages (claimed) | Any dose up to 1.0 mg for semaglutide; up to 7.5 mg for tirzepatide (captured limits) |
| Clinical review | Board-certified physicians review cases; no video call required; asynchronous review | 3-minute online visit; clinician review required |
| Subscriptions and fees | No subscriptions, no membership fees, billed monthly on non-recurring basis; three-month prescriptions billed upfront | No membership fee; promises no price hike month to month |
| Compounded medication note | Offers compounded semaglutide and tirzepatide; compounded meds are not FDA-approved | Notes medication-specific approval status must be confirmed; compounded and branded not interchangeable |
Other facts and limitations from the sources
Oak states patients with BMI below 20 do not qualify for GLP-1 treatment and a separate note says not appropriate for BMI under 22 without comorbidities in other captured fields. Oak also states not for patients under 18, pregnant, or nursing. CoreAgeRx materials captured did not publish full eligibility details or refund/shipping specifics on the reviewed landing page; the captured evidence flags that pricing, eligibility, pharmacy, state coverage, and renewal terms may change.
Start Oak Longevity enrollment
Final comparison and short conclusion
Oak Longevity vs CoreAgeRx comes down to whether you prioritize Oak’s listed low starting prices and no video visit with one-price-for-all-dosages language or CoreAgeRx’s explicit same-price-every-month promise and documented dose caps. Both require licensed clinician review and both include regulatory cautions about compounded medications in the captured evidence.
Choose Oak Longevity if…
You want the lowest listed starting price in the captured evidence, prefer a non-recurring monthly billing option with no subscription, value free health coaching and free shipping, and are comfortable with an asynchronous clinician review and compounded medication options.
Choose CoreAgeRx if…
You prioritize a stated same price every month with no membership fee, want explicit dose caps documented in the captured materials, and prefer a program that highlights a 3-minute online visit as the enrollment step. Verify eligibility, state availability, renewal terms and medication-specific approval status before enrolling, as the captured CoreAgeRx evidence notes those factors may change.